CClinicalTrials.gg
CompletedNCT02503098Updated Oct 6, 2020

Optimizing a Smartphone Application for Individuals With Eating Disorders

An interventional study of Recovery Record adaptive smartphone application and Recovery Record standard smartphone application in Eating Disorders, Binge Eating Disorder and Bulimia Nervosa, sponsored by Recovery Record Research. Completed at 2 sites in United States. Open to participants aged 16 Years and older. Per ClinicalTrials.gov, last updated 2020-10-06.

Sponsored by Recovery Record Research · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
3,340
Allocation
Randomized
Ages
16 Years and older
Sex
All
01

Study summary

This study will augment an existing mobile application for individuals with eating disorders by developing adaptive, tailored content targeting remediation of cognitive distortions. The adaptive application will be deployed and assessed for efficacy relative to the standard product in a randomized controlled trial.

Read the detailed description

Eating Disorders (ED) are common and serious psychological disorders. Anorexia Nervosa (AN) has a prevalence estimated at between 0.48% and 0.70% among young females. Bulimia Nervosa (BN) is a serious mental health problem, with a prevalence of between 1-2% of young women while clinically significant bulimic behaviors occur in an additional 2-3%. There are significant barriers to access of evidence-based treatments and current models of individual psychotherapy will likely never meet the enormous need for psychological services for ED. Unfortunately, even with treatment, rates of recovery are modest with the best performing treatments achieving remission in only about 50% of cases while relapse rates are high, especially if the ED becomes chronic. It is widely acknowledged that a major shift in intervention practice is needed and that smartphone apps will almost certainly play a role due to their reach and breadth of functionality.

As the first commercially available smartphone app for EDs, Recovery Record (RR) has established wide reach and user acceptability. The app provides users with meal and ED symptom self-monitoring and coping skill strategies in an evidence-based CBT format. Preliminary pilot data suggest that for a proportion of RR users, using RR is associated with clinically significant symptom reduction. However, a limitation of the current app is that it is a "one-size-fits-all" product that does not account for the heterogeneity of ED symptoms. Genetic, personality and neurocognitive data support distinct clusters of ED presentations that also differ according to response to treatment, course and outcome. Pilot data confirm that clinical response to RR is not homogenous across groups and that extent of cognitive distortions is the most potent factor to predict outcome. There is considerable opportunity to increase RR's effectiveness across a range of ED symptoms and behaviors by creating adaptive and tailored content focused on remediation of cognitive distortions.

During Phase 1 of this study screening algorithm will be validated against an unseen, prospective test dataset of approximately 2,000 users. All candidate predictor variables will be entered into a Signal Detection Analysis to confirm the sensitivity and specificity of the screen. Informed by the resultant algorithms, adaptive content will be developed that targets ED-specific cognitive distortions. To evaluate acceptability, adapted content will be piloted with approximately 200 individuals for a period of one month. Participant feedback and utilization data will inform content acceptability and feasibility. By the end of the first phase tailored content that is acceptable to individuals with specific symptom presentations will be developed.

Phase 2 will focus on an evaluation of whether an adaptive app offering tailored content addressing eating related cognitive distortions in a stepped way can outperform the current standard app. The adaptive content will be integrated into a new, dynamic version of the app (RR-A) that will then be evaluated against the current app (RR-S). Approximately 5,000 registered users of RR will be randomized to receive either RR augmented with targeted content (RR-A), or RR in its current standard format (RR-S) over a two-month period. Outcome data will be measured at baseline, one month, end of treatment, and at six-month follow-up. At the end of the study period it is predicted that the resultant evidence-based product will have demonstrated ability to bring about clinically significant reduction in symptoms in more users than the current app, and thus will have potential to make a substantial public health impact.

02

Conditions studied

  • Eating Disorders
  • Binge Eating Disorder
  • Bulimia Nervosa

Keywords

  • Eating Disorders
  • Cognitive Behavioral Therapy
  • Mobile Phone
  • Smartphone
  • App
  • Binge Eating Disorder
  • Bulimia Nervosa
  • Signal Detection Analysis
03

In context

Bulimia

319 studies on the registry are indexed under Bulimia; 53 are open to participants now.

This study's enrollment of 3,340 is above the median of 61 across 249 interventional studies indexed under Bulimia.

Browse Bulimia studies →

Lead sponsor

This is the only study on the registry with Recovery Record Research as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Meets criteria for clinically significant symptoms of eating disorder using self-report measures
  • Has an Android or iPhone and is willing to use phone for the study
  • Is able to speak and read English
  • Lives within the United States of America
  • Is at least 16 years of age

Exclusion criteria

Exclusion Criteria:

  • Has visual, hearing, voice, or motor impairment that would prevent completion of study and treatment procedures
  • Has any psychiatric condition for which participation in a clinical trial of psychotherapy may be either inappropriate or dangerous (e.g., psychotic disorders, bipolar disorders, severe post traumatic stress disorder, etc.).
  • Exhibits severe suicidality, including ideation, plan, and intent.
  • Currently receiving weekly psychotherapy or planning to receive weekly psychotherapy for eating disorder during the 12 weeks of the study.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
3,340 participants (actual)

Study arms

  • Experimental
    Recovery Record adaptive smartphone application (RR-A)

    Participants will have access to all Recovery Record standard functions and will additionally receive tailored, algorithm-generated content targeting cognitive distortions.

    Behavioral: Recovery Record adaptive smartphone application

  • Active comparator
    Recovery Record standard smartphone application (RR-S)

    Participants will have access to all Recovery Record standard functions, including meal monitoring, motivational enhancement, social support, and coping skill strategies.

    Behavioral: Recovery Record standard smartphone application

Interventions

  • BehavioralRecovery Record adaptive smartphone application
  • BehavioralRecovery Record standard smartphone application
06

What researchers measure

Primary outcomes

  1. Changes in Eating Disorder Severity

    Self-reported eating disorder symptom severity. To measure changes in eating disorder severity over time, the Eating Disorder Evaluation Questionnaire (EDE-Q) will be used.

    Time frame: Measured at the start of treatment (baseline), week 4, week 8 and 6 months follow-up

Secondary outcomes

  1. Binge eating and purging episode frequency

    Self-reported disordered behavior frequency will be assessed via behaviors self-monitored in the application in addition to symptom frequency questions in the Eating Disorder Evaluation Questionnaire.

    Time frame: Measured at the start of treatment (baseline), week 4, week 8 and 6 months follow-up

  2. Changes in Clinical Impairment Severity

    To measure changes in eating disorder related clinical impairment over time, the self-reported Clinical Impairment Assessment (CIA) will be used.

    Time frame: Measured at the start of treatment (baseline), week 4, week 8 and 6 months follow-up

  3. Participant Satisfaction

    Self-reported satisfaction

    Time frame: Participants will be followed for the duration of the 8-week trial

  4. Adherence to the mobile application intervention

    Adherence will be measured via dichotomous outcome of drop-out (an individual will be considered a system drop-out if they fail to login to the app at all for a period of 14 consecutive days). Adherence will be assessed through application usage data.

    Time frame: Measured from the start of application utilization (baseline) to 8-weeks

  5. Adherence to self-monitoring tasks

    Frequency of self-monitoring entries will be tracked automatically through the program server.

    Time frame: Measured from the start of application utilization (baseline) to 8-weeks

07

Study locations

2 sites
  • Recovery Record Research
    San Francisco, California 94107, United States
  • Stanford University School of Medicine, Department of Psychiatry and Behavioral Sciences
    Stanford, California 94304, United States
08

References and documents

Publications

  • Tregarthen J, Paik Kim J, Sadeh-Sharvit S, Neri E, Welch H, Lock J. Comparing a Tailored Self-Help Mobile App With a Standard Self-Monitoring App for the Treatment of Eating Disorder Symptoms: Randomized Controlled Trial. JMIR Ment Health. 2019 Nov 21;6(11):e14972. doi: 10.2196/14972. PubMed 31750837 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 6, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02503098
Lead sponsor
Recovery Record Research
Collaborators
Stanford University
Responsible party
Sponsor
First posted
Jul 20, 2015
Start date
Nov 23, 2016
Primary completion
Jul 13, 2018
Completion
Sep 13, 2018
Last update
Oct 6, 2020

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion